LivaNova (LIVN) EBIT Growth (1y) (2015 - 2026)
LivaNova (LIVN) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn | 74.18% |
| 10 | LivaNova | 4.39 Bn | 3.85 Bn | 243.75 Mn | -14.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.70% |
| Dec 31, 2025 | 15.01% |
| Sep 30, 2025 | 51.64% |
| Jun 30, 2025 | 34.90% |
| Mar 31, 2025 | 199.26% |
| Dec 31, 2024 | 142.07% |
| Sep 30, 2024 | 698.97% |
| Jun 30, 2024 | 131.16% |
| Mar 31, 2024 | 793.68% |
| Dec 31, 2023 | -730.30% |
| Sep 30, 2023 | 103.38% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -124.64% |
| Dec 31, 2022 | -43.61% |
| Sep 30, 2022 | -903.64% |
| Jun 30, 2022 | 187.57% |
| Mar 31, 2022 | 266.81% |
| Dec 31, 2021 | 109.94% |
| Sep 30, 2021 | 317.45% |
| Jun 30, 2021 | -116.58% |